-+ 0.00%
-+ 0.00%
-+ 0.00%

TEMPEST THERAPEUTICS - CO AND SENLANG TO DEVELOP TPST-4003 WITH TRIAL IN CHINA FOR MG AND MS

Reuters·07/21/2026 11:00:00

Please log in to view news